In the last trading session, 2.55 million Apellis Pharmaceuticals Inc (NASDAQ:APLS) shares changed hands as the company’s beta touched 0.67. With the company’s per share price at $17.67 changed hands at $0.22 or 1.26% during last session, the market valuation stood at $2.22B. APLS’s last price was a discount, traded about -148.95% off its 52-week high of $43.99. The share price had its 52-week low at $16.10, which suggests the last value was 8.89% up since then.
Analysts gave the Apellis Pharmaceuticals Inc (APLS) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.83. If we narrow down to specifics, the data shows that 0 out of 14 analysts rate the stock as a Sell, with a further 1 assigning it an Overweight rating. Of the remaining, 2 recommended APLS as a Hold, 11 felt it is a Buy and 0 rated the stock as Underweight.
Apellis Pharmaceuticals Inc (NASDAQ:APLS) trade information
Instantly APLS was in green as seen at the end of in last trading. With action 0.86%, the performance over the past five days has been green. The company’s shares are showing year-to-date downside of -44.63%, with the 5-day performance at 0.86% in the green. However, in the 30-day time frame, Apellis Pharmaceuticals Inc (NASDAQ:APLS) is -2.91% down.
The consensus price target for the stock as assigned by Wall Street analysts is 76, meaning bulls need an upside of 76.75% from its current market value. According to analyst projections, APLS’s forecast low is 39 with 113 as the target high. To hit the forecast high, the stock’s price needs a -539.5% plunge from its current level, while the stock would need to soar -120.71% for it to hit the projected low.
Apellis Pharmaceuticals Inc (APLS) estimates and forecasts
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 20.08%. The 2025 estimates are for Apellis Pharmaceuticals Inc earnings to decrease by -10.49%.
Apellis Pharmaceuticals Inc (NASDAQ:APLS)’s Major holders
ECOR1 CAPITAL, LLC holds the second largest percentage of outstanding shares, with 9.3681% or 11.61 million shares worth $445.26 million as of 2024-06-30.
Among Mutual Funds, the top two as of Jan 31, 2025 were VANGUARD SPECIALIZED FUNDS-Vanguard Health Care Fund and VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund. With 8.48 shares estimated at $149.8 million under it, the former controlled 6.75% of total outstanding shares. On the other hand, VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund held about 2.60% of the shares, roughly 3.26 shares worth around $57.64 million.
